REFERENCES
- Agresti, A. (2002), Categorical Data Analysis (2nd ed.), New York: Wiley.
- Anderson, T.W. (1962), On the Distribution of the Two-Sample Cramer–Von Mises Criterion, Annals of Mathematical Statistics, 33, 1148–1159.
- Casella, G., and Berger, R.L. (2002), Statistical Inference (2nd ed.), Pacific Grove: Duxbury.
- Collett, D. (2003), Modelling Survival Data in Medical Research (2nd ed.), Boca Raton: Chapman and Hall/CRC.
- Conover, W.J. (1999), Practical Nonparametric Statistics (3rd ed.), New York: Wiley.
- Hernan, M.A. (2010), The Hazards of Hazard Ratios, Epidemiology, 21, 13–15.
- Hosmer, D.W., Lemeshow, S., and May, S. (2008), Applied Survival Analysis: Regression Modeling of Time to Event Data (2nd ed.), New York: Wiley.
- Kalbfleisch, J.D., and Prentice, R.L. (2002), The Statistical Analysis of Failure Time Data (2nd ed.), New York: Wiley.
- Leathem, A.J., Brooks, S.A. (1987), Predictive Value of Lectin Binding on Breast-Cancer Recurrence and Survival, The Lancet, 329, 1054–1056.
- Moser, B.K., McCann, M.H. (2008), Reformulating the Hazard Ratio to Enhance Communication With Clinical Investigators, Clinical Trials, 5, 248–252.
- Rothman, K.J., and Greenland, S. (1998), Modern Epidemiology (2nd ed.), Philadelphia, PA: Lippencott Williams and Wilkens.
- Spruance, S.L., Reid, J.E., Grace, M., Samore, M. (2004), Hazard Ratio in Clinical Trials, Antimicrobial Agents and Chemotherapy, 48, 2787–2792.
- Wellek, S. (1993), A Log-Rank Test for Equivalence of Two Survivor Functions, Biometrics, 49, 877–881.
- Winquist, E., Kirchner, T.S., Segal, R., Chin, J., Lukka, H. (2004), Neoadjuvant Chemotherapy for Transitional Cell Carcinoma of the Bladder: A Systematic Review and Meta-Analysis, Journal of Urology, 171, 561–569.